March 10th, 2011
Podcast 115: Talking about the real-world use of dabigatran with Drs. Elaine Hylek and Samuel Goldhaber
Clinical Conversations, in a collaboration with CardioExchange, has interviewed two expert working clinicians on how best to use dabigatran — a drug poised to supplant warfarin in the prevention of stroke and systemic embolism in patients with atrial fibrillation. The wide ranging discussion with Drs. Elaine Hylek and Samuel Goldhaber includes sections on who should be […]
March 2nd, 2011
Podcast 114: Guidelines for preventing cardiovascular disease in women
We think you’ll find this of interest. The American Heart Association last month issued revised guidelines for preventing cardiovascular disease in women. The change that hits you right off is the title’s shift from “Evidence-Based” to “Effectiveness-Based,” emphasizing the writing committee’s belief that the way things go in clinical trials doesn’t always hold in the more […]
January 27th, 2011
Podcast 113: Hot flashes and escitalopram
The SSRI escitalopram beat out a placebo in ameliorating the frequency and severity of hot flashes in menopausal women. Would cheaper SSRIs also do the trick? We talk with the first author of the JAMA paper. Interview-related links: JAMA paper (free abstract) Physician’s First Watch summary
January 13th, 2011
Podcast 112: MRSA guidelines from IDSA
The Infectious Diseases Society of American last week issued clinical practice guidelines on dealing with methicillin-resistant S. aureus infection. We interview the principal author of those guidelines, Dr. Catherine Liu of the University of California, San Francisco. Dr. Liu responds to the criticism leveled earlier this week against all IDSA guidelines, for their apparent lack of […]
December 17th, 2010
Podcast 111: A look back on the year’s most clinically important developments.
Dr. Danielle Scheurer and Joe Elia have a free-form discussion on what’s happened over the past year. Links to those stories (and, sometimes, interviews) are attached here. If you’d like to suggest another, or comment on our selection, drop us a note in the comments field. Discussion-related links (they are all free links): Rivaroxaban Dabigatran Screening for lung cancer […]
December 3rd, 2010
Podcast 110: ARBs (and anti-hypertensives, generally) pose no measurable cancer risk, meta-analysis shows.
This week’s guest, Dr. Sripal Bangalore, finds no evidence that use of the standard anti-hypertensive drugs increases risks for cancer. His meta-analysis did find, however, an indication that ARBs and ACE inhibitors, when used in combination, increase risks modestly. Even with the short follow-up, Bangalore says clinicians should find reassurance in the results. Listen in. Interview-related links: Physician’s […]
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
